Author Archives: Joline Lim
BIOTECH
PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD
PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing...
Read moreDIGITAL CLINICAL SOLUTION
ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation
AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW...
Read moreBIOTECH
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...
Read moreBIOTECH
Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar’s novel oral plant-based...
Read more